🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Those concerned about unintended consequences and sought alternative approaches to free access (e.g. delayed Green OA) were often demonized and conflated with publishers resisting any thing that might threaten profits 2/n

"Using citation counts and six altmetrics for 38.7M articles published 2011-21, we compare OA and non-OA papers. The results show that there is no universal OAA across all disciplines or impact indicators: ..." 1/3

Clearly we need two-factor authentication (at a minimum) on our manuscript submission systems. ⁦

Whew. #TheOutsiders, Hadestown and HELL'S KITCHEN: Alicia Keys’ Hit Broadway Musical in one glorious NYC weekend.

Interesting to see pro-SciHub librarians trying to block AI crawlers from their websites and institutional repositories. Maybe not as into intellectual communism after all?

I swear to god that if the TSA line is held up so someone can style and photograph their bin, I will not handle that well.

dailynews.ascopubs.org/do/podcast-can…

Oncology Accelerated Approval Confirmatory Trials: When a Failed Trial Is Not a Failed Drug - via Journal of Clinical Oncology. Authors Gautam Mehta, MD Rick Pazdur ascopubs.org/doi/full/10.12… #OCEPublications #OCEProjectConfirm

New from JCO: Redefining Available Therapy in Oncology Accelerated Approval Decisions ascopubs.org/doi/10.1200/JC…

Katherine Van Loon Named Editor-in-Chief of JCO Global Oncology society.asco.org/about-asco/pre… Katherine Van Loon, MD, MPH JCO Global Oncology

An amazing choice to lead JCO Global Oncology Congrats Katherine Van Loon, MD, MPH and looking forward to working with you to expand ASCO's global mission!!!! #globonc

Folks in Virginia: We have same day registration. If you go to vote and find that you aren’t registered, don’t leave. You can register and vote at the precinct.

Could #AI help in finding testing and mutation rates in #cancer literature? It looks promising, says a paper we co-authored with a great team, published in JCO Precision Oncology. The paper says #AI shows potential, but also highlights the need for more advanced AI-powered literature

Winding down this account. Can be found at the same user name on Threads, Insta, and BlueSky.